Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF)
- 1 January 1994
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 5 (1) , 56-77
- https://doi.org/10.2165/00019053-199405010-00008
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- TeicoplaninDrugs, 1994
- Empiric Treatment of Localized Infections in the Febrile Neutropenic Patient with MonotherapyLeukemia & Lymphoma, 1993
- Pharmacoeconomics of Intravenous Drug AdministrationPharmacoEconomics, 1992
- Principles of Pharmacoeconomic Analysis of Drug TherapyPharmacoEconomics, 1992
- Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSFEuropean Journal of Cancer and Clinical Oncology, 1991
- Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and feverEuropean Journal of Cancer and Clinical Oncology, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor PrognosisNew England Journal of Medicine, 1987
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Current Guidelines on the Use of Antibacterial Drugs in Patients with MalignanciesDrugs, 1985